BCR-ABL1 Kinase Domain Mutation (IRMA) by NGS

Utilizes next-generation sequencing (NGS) to identify mutations in the BCR-ABL kinase domain, which can impact the treatment of chronic myelogenous leukemia (CML). It informs treatment strategies.

Also known asbcr-abl1 kinase domain ngsbcr-abl1 irma ngsimatinib resistance testcml drug resistance sequencing
Available viaHome Collection
GenderMale & Female
Contains1 parameters
Earliest reports in28 Working Days
PreparationNo preparation needed

Test included

BCR-ABL1 Kinase Domain Mutation (IRMA) by NGS includes 1 parameter

  • Specimen

Test code

G635

CPT and Loinc codes

Department

  • Genexus Lab Category

Turn around time

28 Working Days

Performing locations

1 labs across India

Specimen vol. and vacutainer information

SpecimenVacutainerVolume
Edta Whole BloodLavender Vacutainer3 ML

Specimen stability information

Edta Whole Blood

BCR-ABL1 Kinase Domain Mutation (IRMA) by NGS

₹11550

Health Checkup Category

Complete Care Packages

BCR-ABL1 Kinase Domain Mutation (IRMA) by NGS Test in Other Cities

Need Assistance? Call 93334-93334 or Request a Callback from our health advisor!